Abstract: Select substituted lysine and branched amino acid salts, compositions containing the same and the use of the foregoing in treating the adverse physiological effects of various diseases, especially skin diseases; in mitigating the effects of aging and environmental factors on skin; and in improving and rejuvenating skin.

Abstract: Zinc di-(dibutyryl lysinate) s, topical compositions comprising the same, and their use in skin lightening/brightening/even toning applications.

Abstract: A method of improving skin health and condition comprising the application of select isohexides to the skin.

Abstract: Method of mitigating or reversing the effect of alopecia comprising applying select aryl alkanones to those areas of the skin suffering hair thinning and/or loss.

Abstract: Compositions comprising select meroterpenes and a linoleic component and the use thereof in regulating the endocannabinoid system (ECS).

Abstract: A method of treating atopic dermatitis and/or psoriasis comprising the application of select dilinoleate isohexides to the skin.

Abstract: A method of treating atopic dermatitis and/or psoriasis comprising the application of select dilinoleate isohexides to the skin.

Abstract: A method of treating atopic dermatitis and/or psoriasis comprising the application of select dilinoleate isohexides to the skin.

Abstract: A method of treating atopic dermatitis and/or psoriasis comprising the application of select dilinoleate isohexides to the skin.

Abstract: Compositions comprising select meroterpenes and a linoleic component and the use thereof in regulating the endocannabinoid system (ECS).

Abstract: Compositions comprising select meroterpenes and a linoleic component and the use thereof in regulating the endocannabinoid system (ECS), especially in controlling and/or reducing the levels of cortisol: thereby having a stress reducing or inhibition effect.

Abstract: A method of improving skin health and condition comprising the application of select isohexides to the skin.

Abstract: Method of mitigating or reversing the effect of alopecia comprising applying select aryl alkanones to those areas of the skin suffering hair thinning and/or loss/

Abstract: A method of treating or inhibiting the symptoms of acute respiratory distress syndrome, especially that associated with Covid-19, said method comprising administering an effective amount of a cytokine and/or innate immune response modulating natural extract, its components or metabolites, or combinations thereof capable of modulating those cytokine and/or innate immune response associated mechanisms associated with acute respiratory distress.

Abstract: A method for treatment of viral infections, especially SARS-CoV-2 infections, said method comprising the administration of hydrolysable tannins.

Abstract: Compositions comprising select meroterpenes and a linoleic component and the use thereof in regulating the endocannabinoid system (ECS), especially in controlling and/or reducing the levels of cortisol: thereby having a stress reducing or inhibition effect.

Abstract: The present invention relates to hair care compositions comprising select benzylidene 2,4-pentanedione compounds and methods for reducing hair damage, especially oxidative hair damage, arising from various hair treatments. In particular, the compositions according to the present teachings contribute to a reduction or lessening in oxidative damage sustained by hair fibers during bleaching, repeated shampooing, dyeing, perming, straightening and other oxidative treatments. The compositions according to the present invention also provide excellent color evenness, sustained color protection, and reduce scalp itching.

Abstract: Benzylidene substituted 2,4-pentanedione compounds without having phenolic hydroxyl group(s) are found to provide photostability to otherwise photosensitive compounds and compositions.

Abstract: Sunscreen compositions are provided for protecting skin from sun-induced damage comprising (i) at least one UV-B and/or UV-A/UV-B sunblock active, (ii) at least one meroterpene and (iii) a dermatological acceptable carrier wherein the meroterpene is free or substantially free of psoralens and has a purity of at least 90% w/w. Preferably, the sunblock active will be a UV-A/UV-B sunblock active. These skin protective compositions may optionally include an effective amount of one or more skin protective ingredients such as antioxidants, vitamins, anti-inflammatory agents, self-tanning agents and mixtures thereof.

Abstract: Novel isohexides and pharmaceutical compositions containing the same as well as methods of using the same in the treatment of psoriasis.